PDCD1 and neoplasm: Within the microenvironment, T cells exhibit high expression of PD-1, while tumor cells prominently express PD-L1, resulting in the continuous activation of the PD-1/PD-L1 pathway, inhibiting T cell’s ability to recognize tumor cells, and compromising the immune system’s attack on tumor cells [16].